Statins, HIV, and CVD
Program Themes
Background
Causes of Increased CVD Risk in Persons Infected With HIV
Changes in Causes of Death for HIV-Diagnosed New Yorkers
Viral and ART Factors Ingredients in an "Atherogenic Soup"
40-Year-Old Man Presents for HIV Care
Top Priority Initiate ART
Contemporary ART More Lipid Neutral
Case Study: 1 Year Later
Follow-Up Lipid Profile
Mean Changes in Blood Lipid Levels for 50 Seroconverters Initiating HAART
CVD Risk in Patients With HIV Infection
Assessment of CV Risk in the HIV-Infected Patient
How Is HIV Unique?
HIV-Specific Lipid Issues
Use of Statins With Protease Inhibitors
National Lipid Association Recommendations
Impact of Statins on Atherosclerosis in HIV
INTREPID
REPRIEVE Trial Design
Concluding Remarks
Abbreviations
Abbreviations (cont)